Product Comparison


  Kedrion Biopharma 00562780601 Kedrion Biopharma 00562780505 Kedrion Biopharma 00562780501 Grifols Therapeutics 13533063102 Kedrion Biopharma 00562780605
McKesson # 848311 848309 848308 420201 848312
Description MICRhoGAM® Ultra-Filtered Plus Rho (D) Immune Globulin (Human), Preservative Free 250 IU (50 mcg) Injection 1 Syringe RhoGAM® Ultra-Filtered Plus Rho (D) Immune Globulin (Human), Preservative Free 1,500 IU (300 mcg) Injection 5 Syringes RhoGAM® Ultra-Filtered Plus Rho (D) Immune Globulin (Human), Preservative Free 1,500 IU (300 mcg) Injection 1 Syringe HyperRHO® S/D Full-Dose Rho (D) Immune Globulin (Human), Preservative Free 1,500 IU (300 mcg) Injection 1 mL 1 Syringe MICRhoGAM® Ultra-Filtered Plus Rho (D) Immune Globulin (Human), Preservative Free 250 IU (50 mcg) Injection 5 Syringes
Manufacturer # 0056278060100562780505005627805011353306310200562780605
Brand MICRhoGAM® Ultra-Filtered PlusRhoGAM® Ultra-Filtered PlusRhoGAM® Ultra-Filtered PlusHyperRHO® S/D Full-DoseMICRhoGAM® Ultra-Filtered Plus
Manufacturer Kedrion BiopharmaKedrion BiopharmaKedrion BiopharmaGrifols TherapeuticsKedrion Biopharma
Invoice MICRHOGAM, SYR PLUS ULTR FILTERED 50MCGRHOGAM, SYR PLUS ULTR FILTERED300MCG (5/BX)RHOGAM, SYR PLUS ULTR FILTERED300MCG SINGLEHYPERRHO , SYR 300MCG/ML 1MLMICRHOGAM, SYR PLUS ULTR FILTERED 50MCG (5/BX)
    Log In to Order   Log In to Order   Log In to Order   Log In to Order   Log In to Order

Comparison

Alternate Manufacturer Number 780601780505780605
Alternate Packaging BX/5EA/1
Generic Drug Code 9139991398913989139891399
NDC Number 0056278060100562780505005627805011353306310200562780605
Product Dating McKesson Acceptable Dating: we will ship >= 60 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 180 days
Quantity 1 Syringe5 Syringes1 Syringe1 Syringe5 Syringes
Strength 250 IU (50 mcg)1,500 IU (300 mcg)1,500 IU (300 mcg)1,500 IU (300 mcg)250 IU (50 mcg)
Volume 1 mL
Application Hemolytic Disease of the Newborn / Suppression of Rh IsoimmunizationHemolytic Disease of the Newborn / Suppression of Rh IsoimmunizationHemolytic Disease of the Newborn / Suppression of Rh IsoimmunizationHemolytic Disease of the Newborn / Suppression of Rh IsoimmunizationHemolytic Disease of the Newborn / Suppression of Rh Isoimmunization
Container Type Prefilled SyringePrefilled SyringePrefilled SyringePrefilled SyringePrefilled Syringe
Country of Origin UnknownUnknownUnknownUnknownUnknown
Dosage Form InjectionInjectionInjectionInjectionInjection
Generic Drug Name Rho (D) Immune Globulin (Human), Preservative FreeRho (D) Immune Globulin (Human), Preservative FreeRho (D) Immune Globulin (Human), Preservative FreeRho (D) Immune Globulin (Human), Preservative FreeRho (D) Immune Globulin (Human), Preservative Free
Storage Requirements Requires RefrigerationRequires RefrigerationRequires RefrigerationRequires RefrigerationRequires Refrigeration
Type IntramuscularIntramuscularIntramuscularIntramuscularIntramuscular
UNSPSC Code 5120180551201805512018055120180551201805
Features and Benefits
  • Each single dose prefilled syringe of MICRhoGAM contains 50 mcg (250 IU) of Rho(D) Immune Globulin (Human)
  • This dose will suppress the immune response to up to 2.5 mL of Rh-positive red blood cells
  • MICRhoGAM is indicated within 72 hours after termination of pregnancy up to and including 12 weeks gestation
  • At or beyond 13 weeks gestation, RhoGAM should be administered instead of MICRhoGAM
  • Thimerosal free
  • Store Refrigerated at 2 to 8 degrees C (36 to 46 degrees F)
  • Store Refrigerated at 2 to 8 degrees C (36 to 46 degrees F)
  • Each single dose prefilled syringe of RhoGAM contains 300 mcg (1500 IU) of Rho(D) Immune Globulin (Human)
  • This is the dose for the indications associated with pregnancy at or beyond 13 weeks unless there is clinical or laboratory evidence of a fetal-maternal hemorrhage (FMH) in excess of 15 mL of Rh-positive red blood cells
  • Thimerosal free
  • Store Refrigerated at 2 to 8 degrees C (36 to 46 degrees F)
  • Store Refrigerated at 2 to 8 degrees C (36 to 46 degrees F)
  • Each single dose prefilled syringe of RhoGAM contains 300 mcg (1500 IU) of Rho(D) Immune Globulin (Human)
  • This is the dose for the indications associated with pregnancy at or beyond 13 weeks unless there is clinical or laboratory evidence of a fetal-maternal hemorrhage (FMH) in excess of 15 mL of Rh-positive red blood cells
  • Thimerosal free
  • Store Refrigerated at 2 to 8 degrees C (36 to 46 degrees F)
  • Store Refrigerated at 2 to 8 degrees C (36 to 46 degrees F)
  • HyperRHO S/D full dose is supplied in a single dose syringe with an attached UltraSafe® Needle Guard
  • Preservative free
  • 300 mcg (1500 IU)
  • Each single dose prefilled syringe of MICRhoGAM contains 50 mcg (250 IU) of Rho(D) Immune Globulin (Human)
  • This dose will suppress the immune response to up to 2.5 mL of Rh-positive red blood cells
  • MICRhoGAM is indicated within 72 hours after termination of pregnancy up to and including 12 weeks gestation
  • At or beyond 13 weeks gestation, RhoGAM should be administered instead of MICRhoGAM
  • Thimerosal free
  • Store Refrigerated at 2 to 8 degrees C (36 to 46 degrees F)
  • Store Refrigerated at 2 to 8 degrees C (36 to 46 degrees F)